• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于用于局部和全身基因治疗的纳米材料包被病毒载体的不断发展的经验教训。

Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.

作者信息

Kasala Dayananda, Yoon A-Rum, Hong Jinwoo, Kim Sung Wan, Yun Chae-Ok

机构信息

Department of Bioengineering, College of Engineering, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul, Republic of Korea.

Department of Pharmaceutics & Pharmaceutical Chemistry, Center for Controlled Chemical Delivery, University of Utah, Salt Lake City, UT 84112, USA.

出版信息

Nanomedicine (Lond). 2016 Jul;11(13):1689-713. doi: 10.2217/nnm-2016-0060. Epub 2016 Jun 27.

DOI:10.2217/nnm-2016-0060
PMID:27348247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5561791/
Abstract

Viral vectors are promising gene carriers for cancer therapy. However, virus-mediated gene therapies have demonstrated insufficient therapeutic efficacy in clinical trials due to rapid dissemination to nontarget tissues and to the immunogenicity of viral vectors, resulting in poor retention at the disease locus and induction of adverse inflammatory responses in patients. Further, the limited tropism of viral vectors prevents efficient gene delivery to target tissues. In this regard, modification of the viral surface with nanomaterials is a promising strategy to augment vector accumulation at the target tissue, circumvent the host immune response, and avoid nonspecific interactions with the reticuloendothelial system or serum complement. In the present review, we discuss various chemical modification strategies to enhance the therapeutic efficacy of viral vectors delivered either locally or systemically. We conclude by highlighting the salient features of various nanomaterial-coated viral vectors and their prospects and directions for future research.

摘要

病毒载体是癌症治疗中很有前景的基因载体。然而,由于病毒载体迅速扩散到非靶组织以及其免疫原性,病毒介导的基因疗法在临床试验中显示出治疗效果不足,导致在疾病部位的滞留不佳,并在患者中引发不良炎症反应。此外,病毒载体有限的靶向性妨碍了向靶组织的有效基因递送。在这方面,用纳米材料修饰病毒表面是一种很有前景的策略,可增强载体在靶组织的积累,规避宿主免疫反应,并避免与网状内皮系统或血清补体发生非特异性相互作用。在本综述中,我们讨论了各种化学修饰策略,以提高局部或全身递送的病毒载体的治疗效果。我们通过强调各种纳米材料包被的病毒载体的显著特征及其未来研究的前景和方向来进行总结。

相似文献

1
Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.关于用于局部和全身基因治疗的纳米材料包被病毒载体的不断发展的经验教训。
Nanomedicine (Lond). 2016 Jul;11(13):1689-713. doi: 10.2217/nnm-2016-0060. Epub 2016 Jun 27.
2
Viral vectors for gene transfer: a review of their use in the treatment of human diseases.用于基因转移的病毒载体:其在人类疾病治疗中的应用综述
Drugs. 2000 Aug;60(2):249-71. doi: 10.2165/00003495-200060020-00002.
3
Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective.利用生物材料克服腺病毒传递优化的障碍:现状与未来展望。
J Control Release. 2021 Apr 10;332:285-300. doi: 10.1016/j.jconrel.2021.02.018. Epub 2021 Feb 21.
4
Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity.腺病毒纳米复合物的最新进展:提高特异性,降低免疫原性。
BMB Rep. 2010 Dec;43(12):781-8. doi: 10.5483/BMBRep.2010.43.12.781.
5
Polymers for viral gene delivery.用于病毒基因递送的聚合物。
Expert Opin Drug Deliv. 2008 Apr;5(4):385-401. doi: 10.1517/17425247.5.4.385.
6
[Developments in gene delivery vectors for ocular gene therapy].[用于眼部基因治疗的基因递送载体的进展]
Med Sci (Paris). 2015 May;31(5):529-37. doi: 10.1051/medsci/20153105015. Epub 2015 Jun 9.
7
Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.通过对腺病毒表面进行基因、化学和机械修饰来改变腺病毒嗜性用于癌症基因治疗。
Expert Opin Drug Deliv. 2016 Jun;13(6):843-58. doi: 10.1517/17425247.2016.1158707. Epub 2016 Mar 16.
8
Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.对用于脑部疾病基因治疗的腺病毒和腺相关载体的免疫反应:免疫突触在理解神经免疫相互作用细胞生物学中的作用。
Curr Gene Ther. 2007 Oct;7(5):347-60. doi: 10.2174/156652307782151498.
9
Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism.探索聚合物在腺病毒介导的基因传递中的作用:逃避免疫反应和重新定向嗜性。
Acta Biomater. 2019 Oct 1;97:93-104. doi: 10.1016/j.actbio.2019.06.059. Epub 2019 Aug 3.
10
Progresses towards safe and efficient gene therapy vectors.安全高效基因治疗载体的研究进展。
Oncotarget. 2015 Oct 13;6(31):30675-703. doi: 10.18632/oncotarget.5169.

引用本文的文献

1
Current views and trends of nanomaterials as vectors for gene delivery since the 21st century: a bibliometric analysis.21世纪以来纳米材料作为基因传递载体的当前观点与趋势:一项文献计量分析
Nanomedicine (Lond). 2025 Mar;20(5):439-454. doi: 10.1080/17435889.2025.2457781. Epub 2025 Jan 29.
2
Therapeutic Controlled Release Strategies for Human Osteoarthritis.人类骨关节炎的治疗性控释策略
Adv Healthc Mater. 2025 Jan;14(2):e2402737. doi: 10.1002/adhm.202402737. Epub 2024 Nov 6.
3
RNA Combined with Nanoformulation to Advance Therapeutic Technologies.RNA与纳米制剂相结合以推进治疗技术。
Pharmaceuticals (Basel). 2023 Nov 21;16(12):1634. doi: 10.3390/ph16121634.
4
Meeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicine.应对当代挑战:兽用纳米材料的发展
Pharmaceutics. 2023 Sep 15;15(9):2326. doi: 10.3390/pharmaceutics15092326.
5
Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?假型慢病毒载体:准备好转化为靶向癌症基因治疗了吗?
Genes Dis. 2022 Apr 2;10(5):1937-1955. doi: 10.1016/j.gendis.2022.03.007. eCollection 2023 Sep.
6
Immunotherapy: A new target for cancer cure (Review).免疫疗法:癌症治愈的新靶点(综述)。
Oncol Rep. 2023 May;49(5). doi: 10.3892/or.2023.8537. Epub 2023 Mar 31.
7
Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines.基于壳聚糖的纳米材料作为疫苗的免疫佐剂和递送载体
Vaccines (Basel). 2022 Nov 11;10(11):1906. doi: 10.3390/vaccines10111906.
8
Nanomedicine and drug delivery to the retina: current status and implications for gene therapy.纳米医学与视网膜递药:现状及对基因治疗的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2022 Dec;395(12):1477-1507. doi: 10.1007/s00210-022-02287-3. Epub 2022 Sep 15.
9
Anti-cancer Virotherapy in Russia: Lessons from the Past, Current Challenges and Prospects for the Future.俄罗斯的抗癌病毒疗法:过去的教训、当前的挑战和未来的前景。
Curr Pharm Biotechnol. 2023;24(2):266-278. doi: 10.2174/1389201023666220516121813.
10
A pH- and Bioreducible Cationic Copolymer with Amino Acids and Piperazines for Adenovirus Delivery.一种用于腺病毒递送的含氨基酸和哌嗪的pH及生物可还原阳离子共聚物。
Pharmaceutics. 2022 Mar 9;14(3):597. doi: 10.3390/pharmaceutics14030597.

本文引用的文献

1
Differential myofiber-type transduction preference of adeno-associated virus serotypes 6 and 9.腺相关病毒血清型6和9的差异肌纤维类型转导偏好
Skelet Muscle. 2015 Nov 10;5:37. doi: 10.1186/s13395-015-0064-4. eCollection 2015.
2
Bio-inspired polymer envelopes around adenoviral vectors to reduce immunogenicity and improve in vivo kinetics.受生物启发的聚合物包膜包裹腺病毒载体,以降低免疫原性并改善体内动力学。
Acta Biomater. 2016 Jan;30:94-105. doi: 10.1016/j.actbio.2015.11.005. Epub 2015 Nov 4.
3
New and improved AAVenues: current status of hemophilia B gene therapy.新型改良的腺相关病毒载体应用途径:B型血友病基因治疗的现状
Expert Opin Biol Ther. 2016;16(1):79-92. doi: 10.1517/14712598.2015.1106475. Epub 2015 Nov 2.
4
Inhibition of MEF2A prevents hyperglycemia-induced extracellular matrix accumulation by blocking Akt and TGF-β1/Smad activation in cardiac fibroblasts.抑制MEF2A可通过阻断心肌成纤维细胞中的Akt以及TGF-β1/Smad激活,来防止高血糖诱导的细胞外基质积聚。
Int J Biochem Cell Biol. 2015 Dec;69:52-61. doi: 10.1016/j.biocel.2015.10.012. Epub 2015 Oct 23.
5
Controlled release strategies for rAAV-mediated gene delivery.用于重组腺相关病毒(rAAV)介导的基因递送的控释策略。
Acta Biomater. 2016 Jan;29:1-10. doi: 10.1016/j.actbio.2015.10.015. Epub 2015 Oct 22.
6
Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.神经降压素受体靶向共表达decorin 和 Wnt 拮抗剂的溶瘤腺病毒在原位胰腺肿瘤模型中的强效抗肿瘤作用。
J Control Release. 2015 Dec 28;220(Pt B):766-82. doi: 10.1016/j.jconrel.2015.10.015. Epub 2015 Oct 22.
7
Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.用于癌症基因治疗的、与溶瘤腺病毒复合的、肝癌靶向肽偶联生物可还原聚合物
J Control Release. 2015 Dec 28;220(Pt B):691-703. doi: 10.1016/j.jconrel.2015.09.068. Epub 2015 Oct 3.
8
Using a magnetic field to redirect an oncolytic adenovirus complexed with iron oxide augments gene therapy efficacy.利用磁场重定向与氧化铁复合的溶瘤腺病毒可增强基因治疗的效果。
Biomaterials. 2015 Oct;65:163-74. doi: 10.1016/j.biomaterials.2015.07.001. Epub 2015 Jul 2.
9
Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.红细胞膜包裹的聚合物纳米颗粒作为纳米疫苗诱导抗肿瘤免疫治疗黑色素瘤。
ACS Nano. 2015 Jul 28;9(7):6918-33. doi: 10.1021/acsnano.5b01042. Epub 2015 Jul 14.
10
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.耐药性的进化后果:不同靶点和生物的共同原则。
Nat Rev Genet. 2015 Aug;16(8):459-71. doi: 10.1038/nrg3922. Epub 2015 Jul 7.